Patents by Inventor Bertrand Sutter

Bertrand Sutter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
    Patent number: 10421755
    Abstract: The present invention relates to salts of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, to methods for making them or their precursors, to pharmaceutical compositions comprising them, and to their use as medicaments.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: September 24, 2019
    Assignee: Novartis AG
    Inventors: Wolfgang Marterer, Mahavir Prashad, Edwin Bernard Villhauer, Liladhar Murlidhar Waykole, James Anthony Vivelo, Bertrand Sutter, Jean-Claude Bianchi, Raeann Wu, Denis Har, Piotr H. Karpinski, Massimo Pignone, Doris Stingelin, Eckart Buerger
  • Pharmaceutical compositions
    Patent number: 10188696
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: January 29, 2019
    Assignees: Novartis AG, Debiopharma S.A.
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS
    Publication number: 20180009801
    Abstract: The present invention relates to salts of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, to methods for making them or their precursors, to pharmaceutical compositions comprising them, and to their use as medicaments.
    Type: Application
    Filed: September 22, 2017
    Publication date: January 11, 2018
    Inventors: Wolfgang Marterer, Mahavir Prashad, Edwin Bernard Villhauer, Liladhar Murlidhar Waykole, James Anthony Vivelo, Bertrand Sutter, Jean-Claude Bianchi, Raeann Wu, Denis Har, Piotr H. Karpinski, Massimo Pignone, Doris Stingelin, Eckart Buerger
  • Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
    Patent number: 9802931
    Abstract: The present invention relates to salts of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, to methods for making them or their precursors, to pharmaceutical compositions comprising them, and to their use as medicaments.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: October 31, 2017
    Assignee: Novartis AG
    Inventors: Wolfgang Marterer, Mahavir Prashad, Edwin Bernard Villhauer, Liladhar Murlidhar Waykole, James Anthony Vivelo, Bertrand Sutter, Jean-Claude Bianchi, Raeann Wu, Denis Har, Piotr H. Karpinski, Massimo Pignone, Doris Stingelin, Eckart Buerger
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160367624
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Application
    Filed: May 12, 2016
    Publication date: December 22, 2016
    Applicants: Novartis AG, DEBIOPHARM S.A.
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • Salts of aza-bicyclic di-aryl ethers and pharmaceuticals thereof
    Patent number: 9365565
    Abstract: The present invention relates to salts of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, to methods for making them or their precursors, to pharmaceutical compositions comprising them, and to their use as medicaments.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: June 14, 2016
    Assignee: Novartis AG
    Inventors: Wolfgang Marterer, Mahavir Prashad, Edwin Bernard Villhauer, Liladhar Murlidhar Waykole, James Anthony Vivelo, Bertrand Sutter, Jean-Claude Bianchi, Raeann Wu, Denis Har, Piotr H. Karpinski, Massimo Pignone, Doris Stingelin, Eckart Buerger
  • SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS
    Publication number: 20160145253
    Abstract: The present invention relates to salts of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, to methods for making them or their precursors, to pharmaceutical compositions comprising them, and to their use as medicaments.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 26, 2016
    Inventors: Wolfgang Marterer, Mahavir Prashad, Edwin Bernard Villhauer, Liladhar Murlidhar Waykole, James Anthony Vivelo, Bertrand Sutter, Jean-Claude Bianchi, Raeann Wu, Denis Har, Piotr H. Karpinski, Massimo Pignone, Doris Stingelin, Eckart Buerger
  • SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS
    Publication number: 20140220125
    Abstract: The present invention relates to salts of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, to methods for making them or their precursors, to pharmaceutical compositions comprising them, and to their use as medicaments.
    Type: Application
    Filed: July 12, 2012
    Publication date: August 7, 2014
    Applicant: NOVARTIS AG
    Inventors: Wolfgang Marterer, Mahavir Prashad, Edwin Bernard Villhauer, Liladhar Murlidhar Waykole, James Anthony Vivelo, Bertrand Sutter, Jean-Claude Bianchi, Raeann Wu, Denis Har, Piotr H. Karpinski, Massimo Pignone, Doris Stingelin, Eckart Buerger
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140005123
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Application
    Filed: December 12, 2011
    Publication date: January 2, 2014
    Applicants: DEBIOPHARM S.A., NOVARTIS AG
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
    Patent number: 7544799
    Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumour therapy.
    Type: Grant
    Filed: September 5, 2006
    Date of Patent: June 9, 2009
    Assignee: Novartis AG
    Inventors: Jürg Zimmermann, Bertrand Sutter, Hans M Bürger
  • Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
    Publication number: 20070004746
    Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumour therapy.
    Type: Application
    Filed: September 5, 2006
    Publication date: January 4, 2007
    Inventors: Jurg Zimmermann, Bertrand Sutter, Hans Burger
  • Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
    Publication number: 20060030568
    Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumour therapy.
    Type: Application
    Filed: September 29, 2005
    Publication date: February 9, 2006
    Inventors: Jurg Zimmermann, Bertrand Sutter, Hans Burger
  • Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
    Publication number: 20050192284
    Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumour therapy.
    Type: Application
    Filed: March 7, 2005
    Publication date: September 1, 2005
    Inventors: Jurg Zimmermann, Bertrand Sutter, Hans Burger
  • Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
    Patent number: 6894051
    Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide of formula 1, which may be used for example for tumor therapy.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: May 17, 2005
    Assignee: Novartis AG
    Inventors: Jürg Zimmermann, Bertrand Sutter, Hans Michael Bürger
  • Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
    Publication number: 20020115858
    Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumor therapy.
    Type: Application
    Filed: November 16, 2001
    Publication date: August 22, 2002
    Inventors: Juerg Zimmermann, Bertrand Sutter, Hans M. Buerger
  • Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
    Patent number: RE43932
    Abstract: The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-yl-methyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula I, which may be used for example for tumour therapy.
    Type: Grant
    Filed: September 21, 2011
    Date of Patent: January 15, 2013
    Assignee: Novartis AG
    Inventors: Juerg Zimmermann, Bertrand Sutter, Hans Michael Buerger